Clinical Trial Update: A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 pilot study to assess feasibility of using decitabine with filgrastim as post-transplant prophylaxis in children and young adults with AML, MDS, and rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Inherited Bone Marrow Failure Syndrome
• Myelodysplastic Syndromes
• Myeloid Neoplasms

Drugs mentioned

• Decitabine (Decitabine)
• Filgrastim (filgrastim)

Snippet

Sponsor: Franziska Wachter | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING